Price $109.81 |
Market Cap
192.33B
|
Sector Health Care |
Div. Growth
8.80%
|
|
P/E
24.7
|
P/B
5.39
|
P/S
4.27
|
Dividend %
1.90%
|
|
P/CF
648.5
|
P/FCF
37.0
|
Op. Cash Flow
10.32M
|
FCF
2.9
|
|
Op. Margin
21.00%
|
Net Margin
17.50%
|
ROE
22.00%
|
ROI
13.50%
|
|
ROA
10.70%
|
EPS Growth
9.90%
|
Current Ratio
1.8
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings Inc (CPHI) | $0.10 | - | - | 5.3M | Strong Buy |
| Evofem Biosciences Inc (EVFM) | $0.05 | - | - | 6.3M | Strong Buy |
| Great Elm Group Inc (GEG) | $2.20 | - | - | 59M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.94 | - | - | 106.2M | Strong Buy |
| Humanigen Inc (HGEN) | $0.17 | - | - | 11.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
